2013
DOI: 10.1179/2050287713z.00000000021
|View full text |Cite
|
Sign up to set email alerts
|

Reflections on the Ethics of Biomaterials Science

Abstract: The subject of biomaterials science concerns artificial materials used in medical devices to repair or reconstruct natural human tissue damaged by disease or trauma. It embraces the emerging field of tissue engineering, where artificial materials are used as scaffolds to provide the architecture for replacement organs. As such, the field raises numerous ethical issues, which are reviewed in this paper. These include the use of animal models, the testing materials and devices in patients, and what may be viewed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 23 publications
(25 reference statements)
0
8
0
Order By: Relevance
“… 74 , 75 Some suggest that consent should be specific to the intended use 17 while others argue that broad consent suffices. 20 , 76 As a prerequisite for consent, donors should be provided relevant information, including information on present and foreseeable use of the collected tissues, 7 , 77–81 on the need to forego financial rights over the tissue, 82 and on policies outlining the return of findings 83 , 84 and the possibility to withdraw. 85 , 86 …”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“… 74 , 75 Some suggest that consent should be specific to the intended use 17 while others argue that broad consent suffices. 20 , 76 As a prerequisite for consent, donors should be provided relevant information, including information on present and foreseeable use of the collected tissues, 7 , 77–81 on the need to forego financial rights over the tissue, 82 and on policies outlining the return of findings 83 , 84 and the possibility to withdraw. 85 , 86 …”
Section: Resultsmentioning
confidence: 99%
“… 22 , 120 Fourth, possible positive bias and conflicting financial or professional interest of the physician-researcher involved in an experimental TE treatment might affect the neutrality of the information provided. 119 , 121–123 And last, uncertainty about possible complications due to the novel, 81 complex, 22 , 119 , 124 invasive, 20 , 118 and irreversible 125 nature of TE makes it difficult to provide accurate information about the risk-benefit ratio of the intervention. 23 , 71 , 88 , 104 , 112 …”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations